Nevro

Yahoo Finance • 9 months ago

Earnings Release: Here's Why Analysts Cut Their Nevro Corp. (NYSE:NVRO) Price Target To US$15.30

Nevro Corp. (NYSE:NVRO) investors will be delighted, with the company turning in some strong numbers with its latest results. Results overall were solid, with revenues arriving 4.1% better than analyst forecasts at US$102m. Higher revenues... Full story

Yahoo Finance • last year

Top 4 Spinal Injury Stocks for 2024 (NRX.V, NVRO, SYK, BSX)

Naples, Florida --News Direct-- CGR Spine Investors eyeing dynamic opportunities in healthcare should take note of the burgeoning growth anticipated in the spinal cord injury market. Projections for robust advancements, driven by enhanced... Full story

Yahoo Finance • last year

Nevro Announces Preliminary Fourth-Quarter and Full-Year 2023 Revenue Results

Fourth-Quarter 2023 Worldwide Revenue Exceeds Company's Expectations Announces Restructuring to Support Company's Long-Term Growth and Profitability REDWOOD CITY, Calif., Jan. 9, 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global me... Full story

Yahoo Finance • last year

Nevro Reports Third Quarter 2023 Financial Results, Provides Fourth Quarter Guidance and Updates Full-Year 2023 Guidance

REDWOOD CITY, Calif., Nov. 1, 2023 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, today reported its third quarter 2023... Full story

Yahoo Finance • 2 years ago

Nevro Announces Participation in Upcoming Investor Conferences

REDWOOD CITY, Calif., April 24, 2023 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, announced today that it is particip... Full story

Yahoo Finance • 2 years ago

Why Nevro Stock Is Tanking Today

Shares of the medical device company Nevro (NYSE: NVRO) were down by an unsightly 18.9% on exceptionally heavy volume at 10:57 a.m. ET Thursday. The big loss came after the company announced that Kevin Thornal will take the reins as CEO an... Full story

Yahoo Finance • 2 years ago

Nevro to Present at 41st Annual J.P. Morgan Healthcare Conference

Monday, January 9, 2023 at 3:45 pm Pacific Time / 6:45 pm Eastern Time REDWOOD CITY, Calif., Dec. 19, 2022 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions fo... Full story

Yahoo Finance • 3 years ago

Nevro and Boston Scientific Announce the Settlement of Their Ongoing Intellectual Property Litigations

Parties Reach an Agreement that Concludes Outstanding Intellectual Property Disputes REDWOOD CITY, Calif., Aug. 1, 2022 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO) and Boston Scientific Corp. (NYSE: BSX) announced today that they have reache... Full story

Yahoo Finance • 3 years ago

Nevro Reports First Quarter 2022 Financial Results, Provides Second Quarter 2022 Guidance and Reiterates Full-Year 2022 Guidance

REDWOOD CITY, Calif., May 4, 2022 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), delivering comprehensive, life-changing solutions for the treatment of chronic pain, today reported its financial results for the first quarter ended March 31, 202... Full story